The authors administered 45-90 mg/day of tacrine to eight patients with
tardive dyskinesia. After 2 weeks of treatment, there was a mean reduction
in tardive dyskinesia scores of 43%. No improvement occurred when a placebo
was used instead of tacrine.
Abstract Teaser